Altamira, LLC

Altamira, LLC, a minority-owned, woman-owned small business partnership based in Durham, North Carolina, provides chemoinformatics software licensing and maintenance alongside accessibility equipment (stairlifts, stairglides, ramps) to federal civilian agencies as a prime contractor on 26 of its 27 recent awards, competing in full-and-open procurements without set-aside designation.

Altamira operates across two distinct product lines. Its chemoinformatics portfolio centers on the Corina Symphony, ChemTunes Liver Biopath, Corina Descriptors, and ChemTunes ToxGPS software platforms — chemical data management, virtual liver modeling, and toxicity prediction tools used for chemical safety assessment and regulatory support. Its accessibility equipment line supplies and installs mobility solutions (stairlifts, stairglides, ramps, lifts) to VA healthcare facilities. Representative prime work includes a $118,775 purchase order from the FDA for ChemTunes Software maintenance and support running through June 2031 (awarded July 1, 2026), a $177,000 FDA order for ChemTune and ToxGPS data and system upgrades (September 2025), recurring EPA software license renewals totaling $12,162 to $13,400 annually for Corina and ChemTunes products (most recent January 2025), and multiple VA stairglide and stairlift contracts ranging from $11,700 to $27,106 each across Veterans Integrated Service Networks 2 and 12 between 2023 and 2024. Altamira also subcontracts through Sigma Defense Systems LLC on Army ISR upgrade work.

Customer concentration divides between software and mobility buyers. The FDA anchors 98% of potential value across three awards ($436 thousand), while the VA's Veterans Integrated Service Networks 2 and 12 account for 93% of recent award count (12 awards, $202 thousand combined). The EPA's Office of Research and Development places recurring software license renewals (eight awards, $141 thousand). These five customer nodes cover 98% of combined potential value. Altamira places one task order under an Indefinite Delivery Contract (47QFLA19D0010).

Activity accelerated in 2024 (eight awards) from a baseline of two awards per year in 2022–2023, then slowed to three awards in 2025 and one in 2026 year to date. Combined potential value across all 27 awards is $821 thousand with $793 thousand obligated (97% execution rate), reflecting high contract maturity and small per-award magnitude — the largest single award is the FDA's $118,775 maintenance order. The vendor's NAICS footprint splits between Software Publishers (eight awards) and Surgical/Medical Instrument Manufacturing (12 awards combined), with PSC concentration in Medical and Surgical Instruments, Equipment, and Supplies (12 awards) and Information Technology Software (11 awards combined).